SEC Form 4 · accession 0001209191-16-113622
Juno Therapeutics, Inc. · JUNO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert Nelsen
Director · 10% Owner
Period of report
Apr 5, 2016
Accepted (ET)
Apr 7, 2016 · 4:24 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001594864
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Apr 5, 2016 | A | 329 | $0.00 | A | 51,153 | D | |
| Common StockF3,F4 | holding | — | — | — | 10,552,390 | I | Held by ARCH Venture Fund VII, L.P. |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Consists of fully vested restricted stock units.
- F2Includes 50,824 shares of Common Stock that the Reporting Person received on March 15, 2016 as a result of the distribution described in footnote 3. Such shares were previously beneficially owned through ARCH Venture Fund VII, L.P.
- F3As reported on a Form 4 filed on March 17, 2016 by ARCH Venture Fund VII, L.P. ("ARCH Fund VII"), ARCH Venture Partners VII, L.P. ("ARCH Partners VII"), ARCH Venture Partners VII, LLC ("ARCH VII LLC"), Keith Crandell, and Clinton Bybee, ARCH Fund VII distributed to its partners 1,000,000 shares of the Issuer's Common Stock on March 15, 2016. The holdings of ARCH Fund VII reported on this Form 4 give effect to such distribution.
- F4These shares are owned directly by ARCH Fund VII. The sole general partner of ARCH Fund VII is ARCH Partners VII. The sole general partner of ARCH Partners VII is ARCH VII LLC. The Reporting Person is a Managing Director of ARCH VII LLC and is deemed to have voting and dispositive power over the shares and may be deemed to beneficially own certain shares held by ARCH Fund VII. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for Section 16 or any other purpose.